Prinston Pharmaceutical Inc. has recalled several versions of Solco Healthcare US Valsartan and Valsartan/Hydrochlorothiazide (HCTZ) tablets, used to treat high blood pressure and heart failure. The recall was initiated because a cancer-causing impurity called N-nitrosodimethylamine (NDMA) was detected in the active ingredient used to make the tablets. This recall affects all lots of these specific medications that have not yet expired and were distributed nationwide across the United States.
The tablets contain a carcinogen impurity that may increase the risk of cancer with long-term exposure. While no immediate injuries have been reported, patients are advised not to stop taking their medication abruptly without a replacement, as untreated high blood pressure can lead to serious cardiovascular events.
Return to pharmacy for refund and replacement guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.